Applied Materials Announces Q2 FY2024 Earnings Webcast and CY2023 WFE Market Summary
April 30, 2024 07:30 ET
|
Applied Materials, Inc.
SANTA CLARA, Calif., April 30, 2024 (GLOBE NEWSWIRE) -- Applied Materials, Inc. will hold a webcast to discuss its second quarter of fiscal 2024 financial results on Thursday, May 16, 2024 at 4:30...
Tenax Therapeutics Announces New U.S. Patent Covering the Use of Levosimendan in Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)
April 30, 2024 07:30 ET
|
Tenax Therapeutics
Broadens IP protection for oral (TNX-103), IV, and subcutaneous use of levosimendan, and its active metabolites (OR1896 and OR1855), in PH-HFpEFProvides U.S. intellectual property (IP) protection...
Daré Bioscience Secures $22 Million in Non-Dilutive Strategic Royalty Financing to Advance Phase 3 First-in-Category Women’s Health Product Candidates through Key Catalysts
April 30, 2024 07:30 ET
|
Daré Bioscience, Inc.
$22 million of non-dilutive capital at close provides significant capital to achieve objectives Upon achieving a pre-specified return threshold, XOMA will make upside-sharing milestone payments...
REPEAT - Complete Solaria Names T.J. Rodgers CEO
April 30, 2024 07:30 ET
|
Complete Solaria Inc.
Complete Solaria names T.J. Rodgers as CEO; Promotes Brian Wuebbels to COO.
XOMA Adds Economic Interests in Three First-in-Category Assets to its Royalty and Milestone Portfolio Including XACIATO™ (clindamycin phosphate) Vaginal Gel 2%
April 30, 2024 07:30 ET
|
XOMA Corporation
Organon, a global women’s healthcare company, initiated XACIATO™ commercial activities in the fourth quarter of 2023 XOMA further expands its late-stage portfolio with synthetic royalty and milestone...
Invivyd Announces $20 Million to $25 Million Improvement in Projected 2024 Year-End Cash Position
April 30, 2024 07:30 ET
|
Invivyd
Improvements realized through comprehensive resource realignment ensuring robust investment in the commercial launch of PEMGARDATM and the discovery of novel monoclonal antibodiesCompany now expects...
MiNK to Provide Corporate Update and First Quarter 2024 Financial Report
April 30, 2024 07:30 ET
|
MiNK Therapeutics
NEW YORK, April 30, 2024 (GLOBE NEWSWIRE) -- MiNK Therapeutics, Inc. (NASDAQ: INKT), a clinical-stage biopharmaceutical company pioneering the discovery, development, and commercialization of...
Full-scale Lilium Jet model to be unveiled for the first time at EBACE2024
April 30, 2024 07:30 ET
|
Lilium GmbH
The first public unveiling of full-scale Lilium Jet model is set to occur next month in GenevaThe Lilium Jet model will be located at Stand A39, as part of Lilium’s largest EBACE presence to date and...
BioRestorative Therapies Announces Transformative Commercial Agreement with Cartessa, a Global Leader in Medical Aesthetics Technology
April 30, 2024 07:30 ET
|
BioRestorative Therapies, Inc
— Leading regenerative medicine and aesthetics innovators collaborate to build a vertically integrated, best-in-class biocosmeceutical platform — — Exclusive, five (5)-year agreement includes...
Libro Credit Union Selects nCino to Empower Employees and Positively Impact Ontario Community
April 30, 2024 07:30 ET
|
nCino, Inc.
TORONTO, April 30, 2024 (GLOBE NEWSWIRE) -- nCino, Inc. (NASDAQ: NCNO), a pioneer in cloud banking for the global financial services industry, today announced that Libro Credit Union has selected...